The article outlines the key steps for transitioning a Laboratory Developed Test (LDT) to an FDA-regulated In Vitro Diagnostic (IVD), focusing on regulatory submissions, quality management systems, and clinical validation. It highlights the importance of ISO 13485 compliance and risk management throughout the process. The guide provides a roadmap for successfully commercializing diagnostic products in the IVD market.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.